This study shows a big cause of chronic inflammation
Inflammation is an essential part of the body’s healing process.
But when it persists, it can contribute to a wide range of complex diseases including...
New variant can increase risk of long COVID, study finds
In a report from the Office for National Statistics (ONS), scientists found that 30% of long COVID sufferers have had symptoms for more than...
Hormone therapy may prevent Alzheimer’s disease in older women
In a study from the University of East Anglia and elsewhere, scientists found that hormone Replacement Therapy (HRT) could help prevent Alzheimer's Dementia among...
High blood pressure drugs are effective at any time of day, study finds
A recent study from the University of Edinburgh and elsewhere found drugs that lower blood pressure is equally effective if taken in the morning...
Uric acid linked to higher risk of irregular heart rhythm
In a study from Karolinska Institutet, scientists found high levels of uric acid in midlife may significantly raise the risk for a serious type...
Widely used diabetes drug may cause dangerous infection
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a new type of drug used to treat diabetes.
A recent study from FDA showed that the drugs could lead...
1 in 2 older Americans with Alzheimer’s disease falls, study finds
With falls causing millions of injuries in older adults each year, it is an increasingly important public health concern.
In a study from Drexel University and elsewhere,...
Managing emotions better may prevent brain disease in older people
Negative emotions, anxiety, and depression are thought to promote the onset of neurodegenerative diseases and dementia.
But what is their impact on the brain and...
When he stopped breathing, his dog called out for help
On a Friday morning in late February, Ken Walsh and his wife, Nicole, sat on their couch in East Brunswick, New Jersey, having coffee...
What the FDA’s accelerated approval of a new Alzheimer’s drug could mean for those...
The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval...